Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03137446 · ClinicalTrials.gov registry record · NA
Restrictive Intravenous Fluids Trial in Sepsis
A NA study, sponsored by Rhode Island Hospital.
- Completed
- Registry status
- NA
- Development phase
- 113
- Enrollment target
NCT03137446 is a NA study that has completed, run by Rhode Island Hospital. The registered enrollment target is 113 participants.
The verdict
NCT03137446, a NA study, has completed, sponsored by Rhode Island Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 113 participants
- Enrollment target
Study Summary
IV fluid resuscitation has long been recognized to be an important treatment for patients with severe sepsis and septic shock. While under-resuscitation is known to increase morbidity and mortality, contemporary data suggests that overly aggressive fluid resuscitation may also be harmful. Currently, following an initial IVF resuscitation of 30 ml/kg, there is no standard of care and a lack of evidence to support a fluid restrictive or more liberal strategy. The investigators seek to determine if a fluid restrictive strategy reduces morbidity and mortality among patients with severe sepsis and septic shock.
Interventions
- OTHER Intravenous Fluid Cap
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 113 participants |
| Start Date | 2017-04-20 |
| Est. Completion | 2018-03-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03137446
The ClinicalTrials.gov registry entry for NCT03137446 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 113 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rhode Island Hospital, which has 130 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Intravenous Fluid Cap is the first listed.
NCT03137446 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03137446 about?
NCT03137446 is a clinical study titled "Restrictive Intravenous Fluids Trial in Sepsis". IV fluid resuscitation has long been recognized to be an important treatment for patients with severe sepsis and septic shock. While under-resuscitation is known to increase morbidity and mortality, contemporary data suggests that overly aggressive fluid resuscitation may also be harmful. Currently,...
What is the current status of trial NCT03137446?
This trial is currently completed. It is a NA study. The enrollment target is 113 participants. The study started on 2017-04-20. Estimated completion is 2018-03-30.
What interventions are being tested in trial NCT03137446?
The interventions under investigation include: Intravenous Fluid Cap (OTHER).
Who is sponsoring clinical trial NCT03137446?
This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.